CATX — Perspective Therapeutics Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Perspective Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3.45	-3.39	-7.27	-46.5	-79.3
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	0.455	0.431	1.12	8.96	29
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-0.835	-0.067	-1.85	2.3	31.8
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-3.64	-2.84	-7.71	-36.9	-18.3
Capital Expenditures	-0.287	-0.411	-0.284	-1.09	-54.5
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0	0.001	0	25.5	-164
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities	-0.287	-0.41	-0.284	24.4	-219
Financing Cash Flow Items	—	—	—	-0.065	0
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.994	64.7	0.056	0.785	289
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-2.93	61.4	-7.94	-11.8	52.2